Polyethersulfone Medical Membrane Market Size (2023-2030)

The Global Polyethersulfone Medical Membrane Market was valued at USD 2.23 billion and is projected to reach a market size of USD 3.60 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 7.1%. 

A polyethersulfone (PES) medical membrane is a particular kind of membrane manufactured from a synthetic polymer of that name. A membrane is a delicate material layer that may divide various elements of a fluid or gas. A medical membrane is a membrane that is employed in a variety of medical processes, such as fluid filtration, medication delivery, and purification. Since polyethersulfone has outstanding mechanical and thermal qualities, it has been widely employed as a promising material in medical applications and waste-treatment membranes. The hydrophobicity of polyethersulfone is viewed as one of the primary drawbacks of employing this substance since the hydrophobic surface results in biofouling effects on the membrane, which has long been regarded to be a severe restriction to the use of polyethersulfone in membrane technology. A potential fix for this issue is the chemical alteration of the material. More precisely, surface modification is a great way to give the polyethersulfone membrane surface hydrophilic characteristics and functional groups. High thermal stability, chemical resistance, mechanical strength, and permeability are just a few benefits that a polyethersulfone medical membrane offers over other types of materials. It is appropriate for sample preparation, sterile filtration, and infusion treatment because it can remove small particles, germs, and fungus from aqueous solutions. It can also be used for hemodialysis, a kidney failure therapy that involves passing blood via a membrane.

Global Polyethersulfone Medical Membrane Market Drivers:

Hemodialysis is a necessary kind of treatment because of the rising incidence of end-stage renal illnesses, diabetes, hypertension, and renal failure:

Patients with chronic kidney disease (CKD), end-stage renal disease (ESRD), renal failure, and other conditions frequently get hemodialysis. With hemodialysis, waste materials, and surplus fluids are removed from the body by filtering the blood via a membrane. The membrane is a component of a dialyzer, commonly referred to as an artificial kidney. A synthetic polymer called polyethersulfone has been utilized as a dialyzer membrane for more than ten years. Because the pore size is substantially more uniform and denser, polyethersulfone dialyzers exhibit enhanced permeability. This implies that it can improve fluid balance and toxin clearance by allowing more solutes and water to flow across the membrane. The polyethersulfone dialyzer also has high biocompatibility, which implies that it doesn't result in negative side effects during hemodialysis including blood clotting, inflammation, or infection. The cost and frequency of replacement are lower because polyethersulfone dialyzers last longer than other types of dialyzers.

The worldwide market for medical membranes is anticipated to be driven by rising polyethersulfone medical membrane applications:

Membrane technology is crucial in many medical applications, especially in several types of life-saving therapy. They are employed in a variety of applications, including medication administration, bioseparations, coatings for medical devices, tissue regeneration, artificial organs, and artificial organs. Membrane applications for biosorting, biosensing, immunoisolation, and drug administration are given for both in vitro and in vivo settings. The production of several kinds of nanoporous materials is described, with a focus on membranes having ordered pores. The demand for desirable membranes used in implanted devices is rising as a result of their biocompatibility and anti-biofouling properties. There are still many obstacles to be solved to produce synthetic nanoporous systems that operate similarly to their biological counterparts, despite the substantial research that has gone into the characterization, production, and modeling of nanoporous materials. The market for medical membranes in growing nations is being driven by the requirement for ultra-pure water for hemodialysis and pharmaceutical manufacturing.

Global Polyethersulfone Medical Membrane Market Challenges:

When compared to other synthetic polymers, polyethersulfone is more expensive, which may prevent its widespread use in specific areas and applications:

One of the elements that could influence the growth of the polyethersulfone market is its price. High-performance polymers like polyethersulfone cost more than other synthetic materials like polyamide and polycarbonate because they need intricate manufacturing and processing procedures. The cost of polyethersulfone granules, according to a website that offers specialized polymers, is approximately 1,800 per kg, or almost $24 per kilogram. As a result, the usage of polyethersulfone may be restricted in particular areas and applications where cost is a considerable factor. Therefore, one of the difficulties for the market for polyethersulfone medical membranes is lowering the cost of polyethersulfone production and processing.

COVID-19 Impact on Global Polyethersulfone Medical Membrane Market:

Germany, France, Italy, Spain, the UK, and Norway are a few of the significant economies affected by the COVID-19 problem. Pharmaceutical filtration, IV Infusion & Sterile filtration, bio-artificial processes, medication administration, and hemodialysis are the main applications for medical membranes, and as a result of the national lockdown, these industries saw a modest slowdown in growth rates. As a result of the suspension of various businesses, particularly transportation and supply chains, the economy has suffered in several nations. The expansion of the chemical sector during the COVID-19 pandemic is anticipated to be hampered by the demand-supply imbalance, interruptions in the acquisition of raw materials, and price instability.

 POLYETHERSULFONE MEDICAL MEMBRANE MARKET REPORT COVERAGE:

Global Polyethersulfone Medical Membrane Market Segmentation: By Technology

• Nanofiltration

• Microfiltration

•  Ultrafiltration

•  Reverse Osmosis

•  Others

Polyethersulfone membranes are used in the process known as nanofiltration to separate molecules according to their size and charge. Water and other fluids may be cleaned using nanofiltration to get rid of pesticides, viruses, and chemical substances.  Using polyethersulfone membranes, the process of microfiltration separates particles according to their size. Water and other fluids can be cleaned by microfiltration of suspended particles, bacteria, fungi, and protozoa. Polyethersulfone membranes are used in the technique of ultrafiltration to separate molecules according to their size and shape. Water and other fluids can be ultrafiltered to get rid of viruses, macromolecules, colloids, and endotoxins.

Polyethersulfone membranes are used in the method known as reverse osmosis to separate molecules according to their solubility and pressure. Water and other fluids can be treated via reverse osmosis to get rid of salts, minerals, chemical compounds, and bacteria. Other techniques that employ polyethersulfone membranes for diverse purposes include membrane distillation, pervaporation, electrodialysis, and gas separation.

According to technology, nanofiltration is the market sector for polyethersulfone medical membranes that is expanding at the highest rate. The rising need for nanofiltration membranes for water purification, pharmaceutical manufacturing, food and beverage processing, and wastewater treatment is what is causing this market segment to expand. Microfiltration is the technique that dominates the market for polyethersulfone medical membranes globally. The broad range of uses of microfiltration membranes for sterile filtration, cell harvesting, protein concentration, and blood purification is credited with this market's supremacy.

Global Polyethersulfone Medical Membrane Market Segmentation: By Application

• Pharmaceutical Filtration

• IV Infusion and Sterile Filtration

• Drug Delivery

• Hemodialysis

• Biological Fluid Filtration

• others

Pharmaceutical filtering is a process that separates and purifies pharmaceutical items such as pharmaceuticals, vaccines, and biologics using polyethersulfone membranes.  Polyethersulfone membranes are used in the IV Infusion and Sterile Filtration application to filter intravenous fluids such as blood, plasma, saline, and medication. Drug Delivery is an application that delivers medications to specified locations in the body using polyethersulfone membranes.

Hemodialysis is a procedure that filters patients with renal failure's blood using polyethersulfone membranes.  In the field of biological fluid filtration, fluids including urine, saliva, cerebrospinal fluid, and synovial fluid are filtered using polyethersulfone membranes.  Other uses for polyethersulfone membranes include the preparation of food and beverages, water purification, industrial wastewater treatment, and gas separation. Drug delivery is the application of polyethersulfone medical membranes that is expanding at the quickest rate. The rising need for controlled-release medication delivery systems for chronic illnesses including diabetes, cancer, and cardiovascular disorders is what's fueling the expansion of this market. Hemodialysis is the most significant application category in the global market for polyethersulfone medical membranes. The domination of this market is related to the increasing incidence of end-stage renal illnesses, diabetes, hypertension, and renal failure, all of which may be treated with hemodialysis.

Global Polyethersulfone Medical Membrane Market Segmentation: By Region

• North America

• Europe

• Asia-Pacific

• South America

• Middle East and Africa

Due to the high incidence of end-stage renal illnesses, diabetes, hypertension, and renal failure, which necessitate hemodialysis as a treatment option, as well as the high prevalence of these conditions, North America is predicted to have the highest share of the worldwide polyethersulfone medical membrane market. According to the National Chronic Kidney Disease Fact Sheet, 15% of Americans, or close to 30 million people, were predicted to have chronic kidney disease (CKD) in 2017. Additionally, the region's established healthcare infrastructure, cutting-edge medical technology, and favorable reimbursement practices all support the market's expansion. Because of the rising need for pharmaceutical filtration, IV infusion and sterile filtration, medication delivery, and biological fluid filtration applications, Europe is anticipated to be the second-largest market for polyethersulfone medical membranes. Additionally boosting market expansion in this area are the expanding geriatric population, rising chronic illness prevalence, and rising pharmaceutical and biotechnology R&D activities.

Key Players:

1. Baxter

2. Fresenius Medical Care Asia Pacific Limited

3. Asahi Kasei Medical Co. Ltd

4. Solvay SA

5. NxStage Medical

6. Farmasol

7. Medica S.p.A.

8. Dialife Group

9. NIPRO

10. Serumwerk Bernburg AG